InsiderTrades

Form 4 for CC Chemours Co

Accepted 2021-08-30 00:00:00 ET · period of report 2021-08-30 · accession 0001627223-21-000045 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-08-30 2021-08-30 CC Ralhan Sameer SVP, CFO S - Sale+OE $35.00 -1,890 298.8K -0.6% -$66.2K
D 2021-08-30 2021-08-30 CC Ralhan Sameer SVP, CFO M - OptEx $18.45 +1,890 300.7K +0.6% +$34.9K
D 2021-08-30 2021-08-30 CC Ralhan Sameer SVP, CFO M - OptEx $0.00 -1,890 17.5K -10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-30 S D 1,890 $35.00 298,792 D — — (F2) Includes directly owned shares, restricted stock units, and dividend equivalent units.
2 Common Common Stock 2021-08-30 M A 1,890 $18.45 300,682 D — — (F2) Includes directly owned shares, restricted stock units, and dividend equivalent units.
3 Derivative Stock Option (Right to Buy) 2021-08-30 M D 1,890 $0.00 17,482 D $18.45 · — to 2022-02-03 1,890 Common Stock (F3) Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016.